HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hibiscus sabdariffa polyphenols alleviate insulin resistance and renal epithelial to mesenchymal transition: a novel action mechanism mediated by type 4 dipeptidyl peptidase.

Abstract
The epithelial to mesenchymal transition (EMT) is important in renal fibrosis. Ser307 phosphorylation of insulin receptor substrate-1 (IRS-1 (S307)) is a hallmark of insulin resistance. We report that polyphenol extracts of Hibiscus sabdariffa (HPE) ameliorate diabetic nephropathy and EMT. Recently it has been observed that type 4 dipeptidyl peptidase (DPP-4) inhibitor linagliptin is effective for treating type 2 diabetes and albuminuria. We investigated if DPP-4 and insulin resistance are involved in renal EMT and explored the role of HPE. In high glucose-stimulated tubular cells, HPE, like linagliptin, inhibited DPP-4 activation, thereby regulating vimentin (EMT marker) and IRS-1 (S307). IRS-1 knockdown revealed its essential role in mediating downstream EMT. In type 2 diabetic rats, pIRS-1 (S307) abundantly surrounds the tubular region, with increased vimentin in kidney. Both the expressions were reduced by HPE. In conclusion, HPE exerts effects similar to those of linagliptin, which improves insulin resistance and EMT, and could be an adjuvant to prevent diabetic nephropathy.
AuthorsChiung-Huei Peng, Yi-Sun Yang, Kuei-Chuan Chan, Chau-Jong Wang, Mu-Lin Chen, Chien-Ning Huang
JournalJournal of agricultural and food chemistry (J Agric Food Chem) Vol. 62 Issue 40 Pg. 9736-43 (Oct 08 2014) ISSN: 1520-5118 [Electronic] United States
PMID25226384 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dipeptidyl-Peptidase IV Inhibitors
  • IRS1 protein, human
  • Insulin Receptor Substrate Proteins
  • Polyphenols
  • Purines
  • Quinazolines
  • Vimentin
  • Linagliptin
  • Dipeptidyl Peptidase 4
  • Glucose
Topics
  • Animals
  • Cells, Cultured
  • Diabetes Mellitus, Experimental (drug therapy, physiopathology)
  • Diabetes Mellitus, Type 2 (drug therapy, physiopathology)
  • Dipeptidyl Peptidase 4 (genetics, metabolism)
  • Dipeptidyl-Peptidase IV Inhibitors (pharmacology)
  • Epithelial-Mesenchymal Transition (drug effects)
  • Glucose (metabolism, pharmacology)
  • Hibiscus (chemistry)
  • Insulin Receptor Substrate Proteins (metabolism)
  • Insulin Resistance
  • Kidney (drug effects, metabolism, pathology)
  • Linagliptin
  • Male
  • Phosphorylation (drug effects)
  • Polyphenols (pharmacology)
  • Purines (pharmacology)
  • Quinazolines (pharmacology)
  • Rats, Sprague-Dawley
  • Vimentin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: